Q-Line Biotech Limited (NSE: QLINE) is a Lucknow, Uttar Pradesh-based company in the Medical Consumables industry. With a market capitalisation of ₹1,280 Cr, it ranks #1,462 by market cap among the 6,197 Indian listed companies on FinBizNet, and #3 of 14 in Medical Consumables. The share price was ₹557.05 as of 19 Nov 2026.
| Current Price | ₹557.05 |
|---|---|
| Market Cap | ₹1,280 Cr |
| NSE Symbol | QLINE |
| Sector | Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies |
| Sub-Industry | Health Care Supplies > Medical Consumables |
| P/E Ratio | 15.7 |
| Return on Equity | 22.63% |
| Return on Assets | 11.76% |
| Beta (1Y) | 1.15 |
| Headquarters | Lucknow, Uttar Pradesh |
| Website | qlinebiotech.com |
Promoters held 67.51% of Q-Line Biotech Limited's shares as of Sept 2026, unchanged from May 2026.
Q-Line Biotech Limited develops, manufactures, and markets various reagents and consumables in India and internationally. It offers reagent kits, rapid cards, consumables, and point-of-care strips for applications in immunodiagnostics, hematology, molecular diagnostics, clinical chemistry, and others, as well as in vitro testing of human samples, supporting disease prediction, prevention, diagnosis, monitoring, and health status evaluation. The company also provides diagnostic equipment comprising analyzers, point-of-care devices, and other critical components for diagnostic procedures; medical equipment maintenance services; and trades in macro cuvettes with balls, lab plastic plates, laboratory plastic tip rack, syringe pumps, and other consumables. In addition, it offers Selectra Pro M, an automatic clinical chemistry analyzer. Further, the company develops Selectra Pro XL, an automatic clinical chemistry analyzer for large laboratories and hospital networks; Mircolab 300, a semi-au
1. Manufacturing-This segment develops, manufactures, and markets various reagents and consumables. 2. Trading-This segment trades in macro cuvettes with balls, lab plastic plates, laboratory plastic tip rack, syringe pumps, and other consumables. 3. Other Unallocable Assets-NA 4. NA-NA
1. Manufacturing-67.4% 2. Trading-32.6%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Poly Medicure Ltd. | ₹17,162 Cr | 53.3 | 10.84% | ₹581 Cr | -14.5% |
| Sahajanand Medical Technologies | ₹4,899 Cr | 77.9 | — | ₹373 Cr | — |
| Q-Line Biotech Limited | ₹1,280 Cr | 15.7 | 22.63% | — | — |
| Laxmi Dental Limited | ₹1,128 Cr | 39.3 | 12.77% | ₹80 Cr | -38.2% |
| Prevest Denpro Ltd | ₹502 Cr | 24.6 | 17.79% | — | -22.6% |
| Choksi Imaging Ltd. | ₹119 Cr | 22.3 | 13.51% | — | +94.0% |
| GSM Foils Limited | ₹72 Cr | 3.9 | 37.54% | ₹97 Cr | -78.3% |
| Mohini Health & Hygiene Ltd | ₹51 Cr | n/m | -17.18% | — | -41.2% |
| KMS Medisurgi Limited | ₹46 Cr | 188.4 | — | — | +4.7% |
Listed by market capitalisation. Ratios are shown for context only.
Q-Line Biotech Limited is trading at ₹557.05, with a market capitalisation of ₹1,280 Cr.
Q-Line Biotech Limited operates in the Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies space (Health Care Supplies > Medical Consumables).
Q-Line Biotech Limited has a P/E of 15.7 and a return on equity of 22.63%.
Q-Line Biotech Limited is listed on the NSE under the symbol QLINE.
Promoters held 67.51% of Q-Line Biotech Limited's shares as of Sept 2026, unchanged from May 2026.
Data as of 19 Nov 2026. Descriptive market data only — not investment advice.